Uncontrollable Crying and Laughter of Pseudobulbar Affect

Mustafa Saad Siddiqui, MD, FAAN, describes the key characteristics of Pseudobulbar affect (PBA) to enable clinicians to recognize, diagnose, and manage this condition.

Dr. Siddiqui has received personal compensation for consulting/serving on a scientific advisory board from AbbVie and Boston Scientific. He has received research support as site PI for clinical trials from Site PI for clinical trials from Sunovion Pharma, Abbvie Inc, Boston Scientific Inc, Biogen MA Inc, Theravance Biopharma, MJ Fox / Neuropoint Alliance, Impax Laboratories, Eli Lilly, Sun Pharma, Biotie therapies, Accord Therapeutics